Prestige Consumer Healthcare (FRA:PBV) 3-Year EBITDA Growth Rate : -70.60% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare 3-Year EBITDA Growth Rate?

Prestige Consumer Healthcare's EBITDA per Share for the three months ended in Dec. 2023 was €1.72.

During the past 12 months, Prestige Consumer Healthcare's average EBITDA Per Share Growth Rate was -97.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -70.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -30.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Prestige Consumer Healthcare was 75.90% per year. The lowest was -70.60% per year. And the median was 11.75% per year.

Competitive Comparison of Prestige Consumer Healthcare's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prestige Consumer Healthcare's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's 3-Year EBITDA Growth Rate falls into.

Prestige Consumer Healthcare 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Prestige Consumer Healthcare (FRA:PBV) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Prestige Consumer Healthcare 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Consumer Healthcare (FRA:PBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (FRA:PBV) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

PBH:USA

Address

660 White Plains Road, Tarrytown, NY, USA, 10591

Website

https://www.prestigebrands.com

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Prestige Consumer Healthcare (FRA:PBV) Headlines

No Headlines